Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Current Trends in the Use of Sedation During Spine Intervention Procedures: A Survey Study.

Hynes A, Vydra D, Clements N, Julia J, Nagpal A, Cushman DM, McCormick ZL.

Pain Med. 2019 Aug 29. pii: pnz194. doi: 10.1093/pm/pnz194. [Epub ahead of print] No abstract available.

PMID:
31504869
2.

Trends in steroid agent and diluent choices for epidural steroid injections: a survey of Spine Intervention Society physicians.

Clements N, Vydra D, Cushman DM, Nagpal A, Julia J, Zheng P, McCormick ZL.

Reg Anesth Pain Med. 2019 May 24. pii: rapm-2018-100366. doi: 10.1136/rapm-2018-100366. [Epub ahead of print]

PMID:
31129616
3.

Current Trends in Steroid Dose Choice and Frequency of Administration of Epidural Steroid Injections: A Survey Study.

Vydra D, McCormick Z, Clements N, Nagpal A, Julia J, Cushman D.

PM R. 2019 May 23. doi: 10.1002/pmrj.12192. [Epub ahead of print]

PMID:
31119858
4.

Left atrial effective conducting size predicts atrial fibrillation vulnerability in persistent but not paroxysmal atrial fibrillation.

Williams SE, O'Neill L, Roney CH, Julia J, Metzner A, Reißmann B, Mukherjee RK, Sim I, Whitaker J, Wright M, Niederer S, Sohns C, O'Neill M.

J Cardiovasc Electrophysiol. 2019 Sep;30(9):1416-1427. doi: 10.1111/jce.13990. Epub 2019 Jun 18.

5.

Current Practice Trends in Image Guidance During Lumbar and Cervical Transforaminal Epidural Steroid Injections.

Vydra D, Hynes A, Clements N, Nagpal A, Julia J, Schneider BJ, Maus TP, Cushman DM, McCormick ZL.

Pain Med. 2019 Apr 2. pii: pnz065. doi: 10.1093/pm/pnz065. [Epub ahead of print] No abstract available.

PMID:
30938803
6.

Microvillus inclusion disease, a diagnosis to consider when abnormal stools and neurological impairments run together due to a rare syntaxin 3 gene mutation.

Julia J, Shui V, Mittal N, Heim-Hall J, Blanco CL.

J Neonatal Perinatal Med. 2019;12(3):313-319. doi: 10.3233/NPM-1852.

PMID:
30909251
7.

Flat plate solar collector performance using alumina nanofluids: Experimental characterization and efficiency tests.

Mondragón R, Sánchez D, Cabello R, Llopis R, Juliá JE.

PLoS One. 2019 Feb 22;14(2):e0212260. doi: 10.1371/journal.pone.0212260. eCollection 2019.

8.

On the relationship between the specific heat enhancement of salt-based nanofluids and the ionic exchange capacity of nanoparticles.

Mondragón R, Juliá JE, Cabedo L, Navarrete N.

Sci Rep. 2018 May 14;8(1):7532. doi: 10.1038/s41598-018-25945-0.

9.

Presence of 16SrIV phytoplasmas of subgroups A, D and E in planthopper Haplaxius crudus Van Duzee insects in Yucatán, Mexico.

Narváez M, Vázquez-Euán R, Harrison NA, Nic-Matos G, Julia JF, Dzido JL, Fabre S, Dollet M, Oropeza C.

3 Biotech. 2018 Jan;8(1):61. doi: 10.1007/s13205-018-1094-5. Epub 2018 Jan 11.

10.

Alternating broad QRS complexes during tachycardia: What is the mechanism?

Juliá J, Whitaker J, Wright M, O'Neill M.

J Cardiovasc Electrophysiol. 2018 Apr;29(4):638-640. doi: 10.1111/jce.13422. Epub 2018 Jan 23. No abstract available.

PMID:
29319203
11.

Nanofluid based on self-nanoencapsulated metal/metal alloys phase change materials with tuneable crystallisation temperature.

Navarrete N, Gimeno-Furio A, Mondragon R, Hernandez L, Cabedo L, Cordoncillo E, Julia JE.

Sci Rep. 2017 Dec 14;7(1):17580. doi: 10.1038/s41598-017-17841-w.

12.

Super-response to cardiac resynchronization therapy may predict late phrenic nerve stimulation.

Juliá J, López-Gil M, Fontenla A, Lozano Á, Villagraz L, Salguero R, Arribas F.

Europace. 2018 Sep 1;20(9):1498-1505. doi: 10.1093/europace/eux311.

PMID:
29182757
13.

Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery: A Randomized Clinical Trial.

Futier E, Lefrant JY, Guinot PG, Godet T, Lorne E, Cuvillon P, Bertran S, Leone M, Pastene B, Piriou V, Molliex S, Albanese J, Julia JM, Tavernier B, Imhoff E, Bazin JE, Constantin JM, Pereira B, Jaber S; INPRESS Study Group.

JAMA. 2017 Oct 10;318(14):1346-1357. doi: 10.1001/jama.2017.14172.

14.

Long-term prognosis of drug-induced Brugada syndrome.

Sieira J, Ciconte G, Conte G, de Asmundis C, Chierchia GB, Baltogiannis G, Di Giovanni G, Saitoh Y, Casado-Arroyo R, Juliá J, La Meir M, Wellens F, Wauters K, Pappaert G, Brugada P.

Heart Rhythm. 2017 Oct;14(10):1427-1433. doi: 10.1016/j.hrthm.2017.04.044. Epub 2017 May 4.

PMID:
28479512
15.

A score model to predict risk of events in patients with Brugada Syndrome.

Sieira J, Conte G, Ciconte G, Chierchia GB, Casado-Arroyo R, Baltogiannis G, Di Giovanni G, Saitoh Y, Juliá J, Mugnai G, La Meir M, Wellens F, Czapla J, Pappaert G, de Asmundis C, Brugada P.

Eur Heart J. 2017 Jun 7;38(22):1756-1763. doi: 10.1093/eurheartj/ehx119.

PMID:
28379344
16.

Recent Patents on Nano-Enhanced Materials for Use in Thermal Energy Storage (TES).

Ferrer G, Barreneche C, Solé A, Juliá JE, Cabeza LF.

Recent Pat Nanotechnol. 2017 Jul 10;11(2):101-108. doi: 10.2174/187221051102170711151312.

PMID:
28049393
17.

Characterization of Tin/Ethylene Glycol Solar Nanofluids Synthesized by Femtosecond Laser Radiation.

Torres-Mendieta R, Mondragón R, Puerto-Belda V, Mendoza-Yero O, Lancis J, Juliá JE, Mínguez-Vega G.

Chemphyschem. 2017 May 5;18(9):1055-1060. doi: 10.1002/cphc.201601083. Epub 2016 Dec 15.

PMID:
27875011
18.

Donor Factors Including Donor Risk Index Predict Fibrosis Progression, Allograft Loss, and Patient Survival following Liver Transplantation for Hepatitis C Virus.

Jesudian A, Desale S, Julia J, Landry E, Maxwell C, Kallakury B, Laurin J, Shetty K.

J Clin Exp Hepatol. 2016 Jun;6(2):109-14. doi: 10.1016/j.jceh.2015.10.005. Epub 2015 Nov 12.

19.

Change in the Grade of Preexcitation and Progressive Prolongation of S-Delta Interval.

Juliá J, López-Gil M, Fontenla A, Lozano Á, Villagraz L, Salguero R, Arribas F.

J Cardiovasc Electrophysiol. 2016 Nov;27(11):1356-1359. doi: 10.1111/jce.13021. Epub 2016 Jun 22. No abstract available.

PMID:
27235378
20.

The Usefulness of Vernakalant in Maintaining Sinus Rhythm During Ablation Procedures.

Juliá J, López-Gil M, Villagraz L, Lozano Á, Fontenla A, Arribas F.

Rev Esp Cardiol (Engl Ed). 2016 Jul;69(7):708-9. doi: 10.1016/j.rec.2016.03.017. Epub 2016 May 24. English, Spanish. No abstract available.

PMID:
27235290
21.

Phrenic paralysis during cardiac electronic device implantation: incidence, causes and clinical course.

López-Gil M, Fontenla A, Juliá J, Parra JJ, Arribas F.

Europace. 2016 Oct;18(10):1561-1564. Epub 2016 Jan 29.

PMID:
26826136
22.

Clinical characterisation and long-term prognosis of women with Brugada syndrome.

Sieira J, Conte G, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G, Di Giovanni G, Saitoh Y, Irfan G, Casado-Arroyo R, Juliá J, La Meir M, Wellens F, Wauters K, Pappaert G, Brugada P.

Heart. 2016 Mar;102(6):452-8. doi: 10.1136/heartjnl-2015-308556. Epub 2016 Jan 6.

PMID:
26740482
23.

Left Free Wall Accessory Pathway Ablation in the Presence of a Mechanical Mitral Prosthesis.

Fontenla A, López-Gil M, Juliá J, Arribas F.

J Cardiovasc Electrophysiol. 2016 Jun;27(6):759-60. doi: 10.1111/jce.12889. Epub 2016 Jan 20. No abstract available.

PMID:
26639028
24.

Asymptomatic Brugada Syndrome: Clinical Characterization and Long-Term Prognosis.

Sieira J, Ciconte G, Conte G, Chierchia GB, de Asmundis C, Baltogiannis G, Di Giovanni G, Saitoh Y, Irfan G, Casado-Arroyo R, Julià J, La Meir M, Wellens F, Wauters K, Pappaert G, Brugada P.

Circ Arrhythm Electrophysiol. 2015 Oct;8(5):1144-50. doi: 10.1161/CIRCEP.114.003044. Epub 2015 Jul 27.

PMID:
26215662
25.

Reply: Early Repolarization: A Risk Factor in Brugada Syndrome.

Conte G, Sieira J, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G, Di Giovanni G, La Meir M, Wellens F, Czapla J, Wauters K, Levinstein M, Saitoh Y, Irfan G, Julià J, Pappaert G, Brugada P.

J Am Coll Cardiol. 2015 Jul 14;66(2):206-7. doi: 10.1016/j.jacc.2015.04.061. No abstract available.

26.

Prognostic value of programmed electrical stimulation in Brugada syndrome: 20 years experience.

Sieira J, Conte G, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G, Di Giovanni G, Saitoh Y, Irfan G, Casado-Arroyo R, Juliá J, La Meir M, Wellens F, Wauters K, Van Malderen S, Pappaert G, Brugada P.

Circ Arrhythm Electrophysiol. 2015 Aug;8(4):777-84. doi: 10.1161/CIRCEP.114.002647. Epub 2015 Apr 22.

PMID:
25904495
27.

Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.

Conte G, Sieira J, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G, Di Giovanni G, La Meir M, Wellens F, Czapla J, Wauters K, Levinstein M, Saitoh Y, Irfan G, Julià J, Pappaert G, Brugada P.

J Am Coll Cardiol. 2015 Mar 10;65(9):879-88. doi: 10.1016/j.jacc.2014.12.031.

28.

When is an Outflow Tract PCV Completely Ablated?

Fontenla A, Castro L, Julia J, Arribas F.

J Cardiovasc Electrophysiol. 2015 Jul;26(7):814-5. doi: 10.1111/jce.12632. Epub 2015 Mar 19. No abstract available.

PMID:
25653120
29.

Regular atrial tachycardias following pulmonary vein isolation for paroxysmal atrial fibrillation: a retrospective comparison between the cryoballoon and conventional focal tip radiofrequency techniques.

Juliá J, Chierchia GB, de Asmundis C, Mugnai G, Sieira J, Ciconte G, Di Giovanni G, Conte G, Baltogiannis G, Saitoh Y, Wauters K, Irfan G, Brugada P.

J Interv Card Electrophysiol. 2015 Mar;42(2):161-9. doi: 10.1007/s10840-014-9961-4. Epub 2015 Jan 20.

PMID:
25597847
30.

P-wave indices as predictors of atrial fibrillation recurrence after pulmonary vein isolation in normal left atrial size.

Mugnai G, Chierchia GB, de Asmundis C, Juliá J, Conte G, Sieira-Moret J, Capulzini L, Wauters K, Rodriguez-Mañero M, Ciconte G, Baltogiannis G, Di Giovanni G, Saitoh Y, Brugada P.

J Cardiovasc Med (Hagerstown). 2016 Mar;17(3):194-200. doi: 10.2459/JCM.0000000000000220.

PMID:
25490249
31.

Follow-up from childhood to adulthood of individuals with family history of Brugada syndrome and normal electrocardiograms.

Conte G, de Asmundis C, Ciconte G, Julià J, Sieira J, Chierchia GB, Brugada P.

JAMA. 2014 Nov 19;312(19):2039-41. doi: 10.1001/jama.2014.13752. No abstract available.

PMID:
25399282
32.

Increment of specific heat capacity of solar salt with SiO2 nanoparticles.

Andreu-Cabedo P, Mondragon R, Hernandez L, Martinez-Cuenca R, Cabedo L, Julia JE.

Nanoscale Res Lett. 2014 Oct 20;9(1):582. doi: 10.1186/1556-276X-9-582. eCollection 2014.

33.

Periprocedural outcomes of prophylactic protamine administration for reversal of heparin after cryoballoon ablation of atrial fibrillation.

Conte G, de Asmundis C, Baltogiannis G, Di Giovanni G, Ciconte G, Sieira J, Saitoh Y, Wauters K, Mugnai G, Julià J, Irfan G, Levinstein M, Cotino-Moreno HE, Chierchia GB, Brugada P.

J Interv Card Electrophysiol. 2014 Nov;41(2):129-34. doi: 10.1007/s10840-014-9922-y. Epub 2014 Jun 18.

PMID:
24938637
34.

Spontaneous and adenosine-induced pulmonary vein reconnection after cryoballoon ablation with the second-generation device.

Ciconte G, Chierchia GB, DE Asmundis C, Sieira J, Conte G, Juliá J, DI Giovanni G, Wauters K, Baltogiannis G, Saitoh Y, Mugnai G, Catanzariti D, Tondo C, Brugada P.

J Cardiovasc Electrophysiol. 2014 Aug;25(8):845-851. doi: 10.1111/jce.12421. Epub 2014 May 2.

PMID:
24678900
35.

One-year follow-up after single procedure Cryoballoon ablation: a comparison between the first and second generation balloon.

Giovanni GD, Wauters K, Chierchia GB, Sieira J, Levinstein M, Conte G, DE Asmundis C, Baltogiannis G, Saitoh Y, Ciconte G, Julia J, Mugnai G, Irfan G, Brugada P.

J Cardiovasc Electrophysiol. 2014 Aug;25(8):834-839. doi: 10.1111/jce.12409. Epub 2014 Apr 9.

PMID:
24641307
36.

Comparison of pulmonary vein isolation using cryoballoon versus conventional radiofrequency for paroxysmal atrial fibrillation.

Mugnai G, Chierchia GB, de Asmundis C, Sieira-Moret J, Conte G, Capulzini L, Wauters K, Rodriguez-Mañero M, Di Giovanni G, Baltogiannis G, Ciconte G, Saitoh Y, Juliá J, Brugada P.

Am J Cardiol. 2014 May 1;113(9):1509-13. doi: 10.1016/j.amjcard.2014.01.425. Epub 2014 Feb 12.

PMID:
24630388
37.

Optimal management of breakthrough cancer pain (BCP).

Escobar Y, Mañas A, Juliá J, Gálvez R, Zaragozá F, Margarit C, López R, Casas A, Antón A, Cruz JJ.

Clin Transl Oncol. 2013 Jul;15(7):526-34. doi: 10.1007/s12094-012-0981-1. Epub 2012 Dec 21. Review.

PMID:
23263914
38.

HER2 blockade in metastatic collecting duct carcinoma (CDC) of the kidney: a case report.

Bronchud MH, Castillo S, Escriva de Romaní S, Mourelo S, Fernández A, Baena C, Murillo J, Julia JC, Esquius J, Romero R, Andreu X.

Onkologie. 2012;35(12):776-9. doi: 10.1159/000345041. Epub 2012 Nov 20.

39.

Breakthrough cancer pain - still a challenge.

Margarit C, Juliá J, López R, Anton A, Escobar Y, Casas A, Cruz JJ, Galvez R, Mañas A, Zaragozá F.

J Pain Res. 2012;5:559-66. doi: 10.2147/JPR.S36428. Epub 2012 Nov 19.

40.
41.

Active anterior rhinomanometry in paediatrics. Normality criteria.

Juliá JC, Burchés ME, Martorell A.

Allergol Immunopathol (Madr). 2011 Nov-Dec;39(6):342-6. doi: 10.1016/j.aller.2010.10.004. Epub 2011 Feb 25.

PMID:
21353365
42.

Necrotising fasciitis of the lower limb due to perforated inguinal hernia.

Georgiev-Hristov T, Álvarez-Gallego M, Juliá JB, Redondo MG, Verón A, Castell-Gómez JT.

Hernia. 2011 Oct;15(5):571-3. doi: 10.1007/s10029-010-0688-6. Epub 2010 Jun 11.

PMID:
20544368
43.

[Major closed-space bleeding in patients on anticoagulation with acenocoumarol (TAO) or non-fractionned heparin(HS): a case-control study].

Martínez Lacasa J, Juan N, Juliá J, Rodríguez-Carballeira M, de Diego I, Soto R, Garau J.

An Med Interna. 2008 Jan;25(1):9-14. Spanish.

PMID:
18377188
44.

Herpes zoster-associated acute urinary retention: a case report.

Julia JJ, Cholhan HJ.

Int Urogynecol J Pelvic Floor Dysfunct. 2007 Jan;18(1):103-4. Epub 2006 Mar 7.

PMID:
16520890
45.

Optimal feature extraction for segmentation of Diesel spray images.

Payri F, Pastor JV, Palomares A, Juliá JE.

Appl Opt. 2004 Apr 1;43(10):2102-11.

PMID:
15074419
46.

Labial fusion causing urinary incontinence in a postmenopausal female: a case report.

Julia J, Yacoub M, Levy G.

Int Urogynecol J Pelvic Floor Dysfunct. 2003 Nov;14(5):360-1. Epub 2003 Sep 10.

PMID:
14618318
47.

[Clinical management in an angiology and vascular surgery unit. Results of the application of a clinical practice protocols].

Juliá J, Gómez FT, Lozano P, Corominas C, Rimbau EM.

Gac Sanit. 2003 Sep-Oct;17(5):430-2. Spanish.

48.

Clinical microbiological case: esophageal lesion in an AIDS patient.

Canet JJ, Julià J, Martínez-Lacasa J, Garau J.

Clin Microbiol Infect. 2003 May;9(5):421, 463-6. No abstract available.

49.

Pulmonary capillary hemangiomatosis associated with primary pulmonary hypertension: report of 2 new cases and review of 35 cases from the literature.

Almagro P, Julià J, Sanjaume M, González G, Casalots J, Heredia JL, Martínez J, Garau J.

Medicine (Baltimore). 2002 Nov;81(6):417-24. Review.

50.

On-line monitoring of one-step laser fabrication of micro-optical components.

Juliá JE, Soriano JC.

Appl Opt. 2001 Jul 1;40(19):3220-4.

PMID:
11958263

Supplemental Content

Support Center